Consumer Healthcare Products Association
Registered Principal Details
Business Or Interest:
A member-based trade association, CHPA represents the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements.
Lobbying Interests:
- Preserving consumer access to over-the-counter medications. - The development of legislation related to establishing the National Precursor Log Exchange (NPLEx) system in Wisconsin
CEO Name:
Scott Melville
A member-based trade association, CHPA represents the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements.
Lobbying Interests:
- Preserving consumer access to over-the-counter medications. - The development of legislation related to establishing the National Precursor Log Exchange (NPLEx) system in Wisconsin
CEO Name:
Scott Melville
Contact
RM
Robbie McLuckie
1635 I Street NW Suite 600
Washington, DC 20006
(202) 429-3524
john.mannion@skadden.com
1635 I Street NW Suite 600
Washington, DC 20006
(202) 429-3524
john.mannion@skadden.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Jordan Lamb | Exclusive Duties N/A | Authorized On 12/20/2016 | Withdrawn On N/A |
| John W Webendorfer | Exclusive Duties N/A | Authorized On 12/20/2016 | Withdrawn On N/A |
| Carlos Gutierrez | Exclusive Duties N/A | Authorized On 1/10/2017 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 306
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
5/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
For
Notification Date5/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 681
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
Bill Text and History
2017 Wisconsin Act 160
12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
Bill Text and History
2017 Wisconsin Act 160
For
Notification Date12/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 764
Relating to: the purchase of pseudoephedrine products and providing a criminal penalty.
Bill Text and History
1/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the purchase of pseudoephedrine products and providing a criminal penalty.
Bill Text and History
Other
Notification Date1/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 237
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
5/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
For
Notification Date5/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 587
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
Bill Text and History
1/17/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
Bill Text and History
For
Notification Date1/17/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 683
Relating to: the purchase of pseudoephedrine products and providing a criminal penalty.
Bill Text and History
1/5/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the purchase of pseudoephedrine products and providing a criminal penalty.
Bill Text and History
Other
Notification Date1/5/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
2019-21 State Budget Bill
2019-21 State Budget Bill
Action Intended To Affect
Both Legislative matter and rule
Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Legislation to restrict minors' access to cough medicine containing Dextromethorphan
Legislation to restrict minors' access to cough medicine containing Dextromethorphan
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/18/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development of legislation related to establishing the National.Precursor Log Exchange (NPLEx) system in Wisconsin
Development, drafting or introduction of a proposal relating to
Development of legislation related to establishing the National.Precursor Log Exchange (NPLEx) system in Wisconsin
Development of legislation related to establishing the National.Precursor Log Exchange (NPLEx) system in Wisconsin
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Preserving consumer access to over-the-counter medications
Preserving consumer access to over-the-counter medications
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/6/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $18,992.60 |
2017 July - December $21,029.50 |
2018 January - June $8,466.25 |
2018 July - December $60.00 |
Total $48,548.35 |
| Total Hours Communicating | 2017 January - June 28.00 |
2017 July - December 17.15 |
2018 January - June 7.75 |
2018 July - December 0.00 |
Total 52.90 |
| Total Hours Other | 2017 January - June 34.10 |
2017 July - December 58.75 |
2018 January - June 17.55 |
2018 July - December 0.20 |
Total 110.60 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: tracking the sale of pseudoephedrine products.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 35% |
2017 July - December 30% |
2018 January - June |
2018 July - December |
Total 28% |
Relating to: tracking the sale of pseudoephedrine products.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 35% |
2017 July - December 30% |
2018 January - June |
2018 July - December |
Total 28% |
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 40% |
2018 January - June 45% |
2018 July - December |
Total 25% |
Relating to: prohibiting the sale of dextromethorphan without a prescription to persons under 18 and providing a penalty. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 45% |
2018 July - December |
Total 7% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 4% |
Development of legislation related to establishing the National.Precursor Log Exchange (NPLEx) system in Wisconsin
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 4% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 4% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 10% |
2018 July - December 100% |
Total 2% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.